Opiate Dependence Clinical Trial
Official title:
Reengineering Methadone Treatment: A Randomized Clinical Trial
Verified date | December 2017 |
Source | Friends Research Institute, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the study is to determine whether a change in the rules and staff roles in methadone treatment programs will result in greater lengths of stay in treatment and lower rates of heroin and cocaine use, crime and HIV-risk behavior as compared to methadone treatment as usual.
Status | Completed |
Enrollment | 300 |
Est. completion date | August 2015 |
Est. primary completion date | April 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - opiate dependence - newly admitted to methadone treatment Exclusion Criteria: - pregnancy |
Country | Name | City | State |
---|---|---|---|
United States | Institutes for Behavior Resources REACH | Baltimore | Maryland |
United States | University of Maryland Drug Treatment Center | Baltimore | Maryland |
Lead Sponsor | Collaborator |
---|---|
Friends Research Institute, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants With Opiate Positive Urine Tests | Number of participants with opiate positive urine tests | 12-months post-baseline | |
Secondary | Number of Participants With Cocaine Positive Urine Tests | Cocaine positive urine drug test | 12-months post-baseline | |
Secondary | Drug Use HIV Risk Behavior | HIV Drug Use Risk Assessment Battery Score ranges from 0 to 22. A higher score is considered to be associated with higher risk. | 12-months post-baseline | |
Secondary | Criminal Behavior | Days of criminal behavior | 12-months post-baseline | |
Secondary | Global Score on the World Health Organization Quality of Life Measure | Scale from 1 through 5. A higher score reflects a better quality of life. | 12-months post-baseline | |
Secondary | Number of Participants Meeting DSM-IV Opiate Dependence Criteria | Diagnostic and Statistical Manual (DSM)-IV criteria for opiate dependence | 12-months post-baseline | |
Secondary | Number of Participants Meeting DSM-IV Cocaine Dependence Criteria | Number of participants meeting DSM-IV cocaine dependence criteria | 12-months post-baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Completed |
NCT01690546 -
Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence
|
Phase 2 | |
Completed |
NCT01389167 -
Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia
|
Phase 3 | |
Completed |
NCT01182402 -
Electronic Compliance Monitoring in Opioid Substitution Treatment
|
N/A | |
Completed |
NCT00634803 -
Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
|
Phase 1/Phase 2 | |
Completed |
NCT00987961 -
Linking Hospitalized Injection Drug Users to Buprenorphine
|
Phase 3 | |
Completed |
NCT00566969 -
Cocaine Withdrawal and Pharmacotherapy Response
|
N/A | |
Completed |
NCT00539123 -
Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia
|
N/A | |
Completed |
NCT00757744 -
Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China
|
Phase 3 | |
Completed |
NCT00577408 -
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
|
Phase 3 | |
Recruiting |
NCT00241930 -
Integrating Buprenorphine Into HIV Treatment
|
Phase 4 | |
Completed |
NCT00218621 -
The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome - 1
|
Phase 2 | |
Completed |
NCT00406484 -
Brief Introductory Therapy for Opioid Dependence
|
Phase 2 | |
Completed |
NCT00580827 -
Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers
|
N/A | |
Completed |
NCT03015597 -
Pilot Study of Contingency Management for Smoking Cessation
|
N/A | |
Completed |
NCT01393392 -
Developing a Smoking Cessation Intervention for Methadone Maintained Smokers
|
Phase 1 | |
Completed |
NCT01416584 -
A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment
|
N/A | |
Recruiting |
NCT00439049 -
Substance Abuse Pre-Treatment Screening Study
|
||
Withdrawn |
NCT00398008 -
HIV Risk Reduction and Drug Abuse Treatment in Iran
|
Phase 2 | |
Completed |
NCT00622596 -
Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance
|
N/A |